[Federal Register Volume 86, Number 75 (Wednesday, April 21, 2021)]
[Notices]
[Page 20713]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08165]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-823]


Bulk Manufacturer of Controlled Substances Application: Research 
Triangle Institute

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Research Triangle Institute, has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before June 21, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before June 21, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 18, 2021, Research Triangle Institute, 3040 
East Cornwallis Road, Hermann Building, Room 106, Research Triangle 
Park, North Carolina 27709, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols...................    7370  I
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substance synthetically only for distribution to its customers for 
research and analytical reference standards. No other activity for this 
drug code is authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08165 Filed 4-20-21; 8:45 am]
BILLING CODE P